Novo Nordisk and Microsoft to collaborate on drug development using AI
The Danish drugmaker’s research and development division gains access to Microsoft’s data and knowledge of artificial intelligence.
by marketwire, translated by daniel pedersen
On Monday, Novo Nordisk and Microsoft announced in a press release a new strategic collaboration that will combine the pharmaceutical firm’s drug discovery machine with the tech giant’s artificial intelligence and cloud services.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg)
